The WBC count, CRP, and D-dimer were significantly higher during the study period, whereas Lys (from T0 to T2) and APTT (T2) were obviously lower in ESS patients than those of non-ESS patients. This evidence concerns the gene CRP and endometrioid stromal sarcoma.